The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

CRISPR Therapeutics is anticipated to report higher revenues but a year-over-year decline in earnings for the quarter ended September 2025, with analyst expectations suggesting a possible earnings ...

Morningstar ( ($MORN) ) has shared an update. Morningstar, Inc. has addressed investor inquiries received up to September 30, 2025, focusing on ...

Exchange-traded funds (ETFs) remain an attractive investment vehicle for investors seeking attractive returns with lesser ...

Morningstar Inc. (NASDAQ:MORN) is a global financial services firm headquartered in Chicago, Illinois. Founded in 1984 by Joe Mansueto, the company provides independent investment research, data, and ...

Invesco QQQ tracks the NASDAQ-100 Index. It contains 101 holdings, with sector weights leaning heavily toward technology (64%), followed by consumer discretionary ( ...

Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...

Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

Learn more about whether BioMarin Pharmaceutical Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.